BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 9699705)

  • 41. Clozapine-induced neuroleptic malignant syndrome.
    DasGupta K; Young A
    J Clin Psychiatry; 1991 Mar; 52(3):105-7. PubMed ID: 2005072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroleptic malignant syndrome induced by atypical antipsychotics.
    Farver DK
    Expert Opin Drug Saf; 2003 Jan; 2(1):21-35. PubMed ID: 12904122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY; Wu PC; Chen CY; Chen YC
    Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. It's all atypical: can clozapine cause atypical neuroleptic malignant syndrome?
    Nama S; Aftab M
    Aust N Z J Psychiatry; 2012 Mar; 46(3):280-1. PubMed ID: 22391291
    [No Abstract]   [Full Text] [Related]  

  • 45. Frequency and presentation of neuroleptic malignant syndrome in a state psychiatric hospital.
    Keck PE; Sebastianelli J; Pope HG; McElroy SL
    J Clin Psychiatry; 1989 Sep; 50(9):352-5. PubMed ID: 2570064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroleptic malignant syndrome associated with clozapine treatment.
    Tsai G; Crisostomo G; Rosenblatt ML; Stern TA
    Ann Clin Psychiatry; 1995 Jun; 7(2):91-5. PubMed ID: 8556099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequency and presentation of neuroleptic malignant syndrome: a prospective study.
    Keck PE; Pope HG; McElroy SL
    Am J Psychiatry; 1987 Oct; 144(10):1344-6. PubMed ID: 2889378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.
    Sachdev P; Kruk J; Kneebone M; Kissane D
    J Clin Psychopharmacol; 1995 Oct; 15(5):365-71. PubMed ID: 8830069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroleptic malignant syndrome with risperidone.
    Gleason PP; Conigliaro RL
    Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Neuroleptic malignant syndrome in users of risperidone].
    Gerritsen AA; de Jonghe-Rouleau AP; Stienstra-Liem LH
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1801-4. PubMed ID: 15495506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atypical Neuroleptic Malignant Syndrome: Case Reports and Diagnostic Challenges.
    Szota AM; Radajewska I; Araszkiewicz AS
    J Psychoactive Drugs; 2022; 54(3):284-293. PubMed ID: 34340640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atypical neuroleptic malignant syndrome and atypical antipsychotics.
    Buckley PF; Hasan S
    Am J Psychiatry; 1998 Nov; 155(11):1633. PubMed ID: 9812143
    [No Abstract]   [Full Text] [Related]  

  • 53. Novel antipsychotics and neuroleptic malignant syndrome.
    Buckley P
    Psychiatr Serv; 1996 Apr; 47(4):431. PubMed ID: 8689381
    [No Abstract]   [Full Text] [Related]  

  • 54. Side effects of antipsychotics in the elderly.
    Masand PS
    J Clin Psychiatry; 2000; 61 Suppl 8():43-9; discussion 50-1. PubMed ID: 10811243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F; Geerlings CJ; Rietveld AP
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract]   [Full Text] [Related]  

  • 56. High-dose vitamin E plus vitamin B6 treatment of risperidone-related neuroleptic malignant syndrome.
    Dursun SM; Oluboka OJ; Devarajan S; Kutcher SP
    J Psychopharmacol; 1998; 12(2):220-1. PubMed ID: 9694035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].
    Weller M; Kornhuber J
    Fortschr Neurol Psychiatr; 1993 Jun; 61(6):217-22. PubMed ID: 8330832
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Case Report: Atypical Neuroleptic Malignant Syndrome on Clozapine and Mood Stabilizers.
    Amador EC; Kassam A; Hopp C; Cunningham EA
    J Clin Psychopharmacol; 2019; 39(5):518-519. PubMed ID: 31425460
    [No Abstract]   [Full Text] [Related]  

  • 59. Neuroleptic malignant syndrome associated with clozapine monotherapy.
    Thornberg SA; Ereshefsky L
    Pharmacotherapy; 1993; 13(5):510-4. PubMed ID: 8247922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone.
    Teng PR; Lane HY
    J Neuropsychiatry Clin Neurosci; 2011; 23(4):E16-7. PubMed ID: 22231327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.